FDA — authorised 13 July 1984
- Marketing authorisation holder: BRAINTREE
- Status: approved
FDA authorised Miralax on 13 July 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 13 July 1984.
BRAINTREE holds the US marketing authorisation.